Background Significant delays still occur in the diagnosis of spinal tuberculosis [sTB] and there is little consensus on the follow-up and duration of treatment. Current UK and international guidelines for sTB still recommend standard short course chemotherapy but this does not reflect clinical practise.
Aims and methods We performed a retrospective study at a UK teaching hospital to identify the demographic and clinical features of our sTB population and the value of spinal magnetic resonance studies [MR] in guiding response to and duration of treatment.
Results Data was available for 26 patients [2005–2011] with an average age of 40 years [60% male]. Mean time to diagnosis was 9.3 months. At presentation the commonest symptoms were back pain –26/26, constitutional symptoms [fevers, sweats, weight loss] – 12/26 and neurological symptoms – 12/26. In 13/26 [50%], the diagnosis was made following an emergency admission. Positive microbiology was obtained in 19/26 and 84% of these were fully sensitive organisms. 42% had disease at multiple spinal levels and 73% had associated paraspinal abscesses. At 6 months only 2/26 [7%] had MR evidence of resolution of active disease and 11/26 [42%] had persisting symptoms [back pain and neurological symptoms]. The median number of follow-up scans/patient was 2 and mean duration of treatment was 10.7 months. Of the 24 patients who received >6 months treatment, 5 [20%] still had symptoms after completion [back pain].
Conclusions MR provides a useful means of assessing response to treatment and can help in deciding duration of treatment. However the frequency/intervals at which scans should be done is not clear.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.